{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:15:14Z","timestamp":1787948114680,"version":"build-2784847793"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf00877958","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T22:02:55Z","timestamp":1111615375000},"page":"55-62","source":"Crossref","is-referenced-by-count":11,"title":["The place of diuretics in the treatment of hypertension: A historical review of classical experience over 30 years"],"prefix":"10.1007","volume":"7","author":[{"given":"Alain G.","family":"Dupont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"233","volume":"15","author":"RS Megibow","year":"1948","unstructured":"Megibow RS, Pollak H, Stollerman GH, et al. The treatment of hypertension by accelerated sodium depletion.J Mt Sinai Hosp NY 1948;15:233?239.","journal-title":"J Mt Sinai Hosp NY"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1021\/ja01565a079","volume":"71","author":"FC Novello","year":"1957","unstructured":"Novello FC, Sprague J. Benzothiazine dioxides as novel diuretics.J Am Chem Soc 1957;71:2028?2029.","journal-title":"J Am Chem Soc"},{"key":"CR3","first-page":"69","volume":"8","author":"W Hollander","year":"1957","unstructured":"Hollander W, Wilkins RW. Chlorothiazide: A new type of drug for the treatment of arterial hypertension.Boston Med Q 1957;8:69?75.","journal-title":"Boston Med Q"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1056\/NEJM195711212572105","volume":"257","author":"RW Wilkins","year":"1957","unstructured":"Wilkins RW. New drugs for hypertension with special reference to chlorothiazide.N Engl J Med 1957;257:1026?1030.","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.1958.02990020025004","volume":"166","author":"ED Freis","year":"1958","unstructured":"Freis ED, Wanko A, Silson IM, et al. Treatment of essential hypertension with chlorothiazide (Diuril).JAMA 1958;166:137?140.","journal-title":"JAMA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0025-7125(16)30818-5","volume":"71","author":"M Moser","year":"1987","unstructured":"Moser M. Diuretics in the management of hypertension.Med Clin North Am 1987;71:935?946.","journal-title":"Med Clin North Am"},{"issue":"Suppl 3","key":"CR7","first-page":"S43","volume":"5","author":"ED Frohlich","year":"1987","unstructured":"Frohlich ED. Diuretics in hypertension.J Hypertens 1987;5(Suppl 3):S43-S49.","journal-title":"J Hypertens"},{"key":"CR8","first-page":"179","volume-title":"The kidney in hypertension","author":"BD Rose","year":"1987","unstructured":"Rose BD, Tinka LA. Diuretics. In: Kaplan NM, Brenner BM, Laragh JH, eds.The kidney in hypertension. New York: Raven Press, 1987:179?196."},{"key":"CR9","first-page":"2143","volume-title":"Hypertension: Pathophysiology, diagnosis and management","author":"MS Pecker","year":"1990","unstructured":"Pecker MS. Pathophysiologic effects and strategies for long-term diuretic treatment of hypertension. In: Laragh JH, Brenner BM, eds.Hypertension: Pathophysiology, diagnosis and management. New York: Raven Press, 1990:2143?2167."},{"key":"CR10","first-page":"127","volume-title":"The kidney in hypertension","author":"NM Kaplan","year":"1987","unstructured":"Kaplan NM. Principles of antihypertensive drug therapy: An overview. In: Kaplan NM, Brenner BM, Laragh JM, eds.The kidney in hypertension. New York: Raven Press, 1987:127?144."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.pa.07.040167.002151","volume":"7","author":"L Tobian","year":"1967","unstructured":"Tobian L. Why do diuretics lower blood pressure in essential hypertension?Ann Rev Pharmacol 1967;7:399?408.","journal-title":"Ann Rev Pharmacol"},{"issue":"Suppl 2","key":"CR12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00004872-199006002-00002","volume":"8","author":"WH Birkenh\u00e4ger","year":"1990","unstructured":"Birkenh\u00e4ger WH. Diuretics and blood pressure reduction: Physiologic aspects.J Hypertens 1990;8(Suppl 2):S3-S7.","journal-title":"J Hypertens"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM196006232622502","volume":"252","author":"ED Frohlich","year":"1960","unstructured":"Frohlich ED, Schnaper HW, Wilson IM, et al. Hemodynamic alterations in hypertensive patients due to chlorothiazide.N Engl J Med 1960;252:1261?1263.","journal-title":"N Engl J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-8703(75)90156-8","volume":"89","author":"G Lohm\u00f6ller","year":"1975","unstructured":"Lohm\u00f6ller G, Lohm\u00f6ller R, Pfeffer MA, et al. Mechanisms of immediate hemodynamic effects of chlorothiazide.Am Heart J 1975;89:487?492.","journal-title":"Am Heart J"},{"key":"CR15","first-page":"21","volume":"22","author":"J Conway","year":"1967","unstructured":"Conway J, Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide.Circulation 1967;22:21?22.","journal-title":"Circulation"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.CIR.41.4.709","volume":"41","author":"RC Tarazi","year":"1970","unstructured":"Tarazi RC, Dustan HP, Frohlich ED. Long-term thiazide therapy in essential hypertension: Evidence for persistent alterations in plasma volume and renin activity.Circulation 1970;41:709?717.","journal-title":"Circulation"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/01.CIR.26.3.405","volume":"26","author":"IM Wilson","year":"1962","unstructured":"Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide.Circulation 1962;26:405?408.","journal-title":"Circulation"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.24.4.788","volume":"24","author":"BM Winer","year":"1961","unstructured":"Winer BM. The antihypertensive mechanism of salt depletion induced by hydrochlorothiazide.Circulation 1961;24:788?796.","journal-title":"Circulation"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.28.1.89","volume":"28","author":"WR Wilson","year":"1963","unstructured":"Wilson WR, Okun R. The acute hemodynamic effects of diazoxide in man.Circulation 1963;28:89?93.","journal-title":"Circulation"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-2999(81)90068-6","volume":"75","author":"J Mironneau","year":"1981","unstructured":"Mironneau J, Savineau JP, Mironneau C. Compared effects of indapamide, hydrochlorothiazide and chlortalidone on electrical and mechanical activities in vascular smooth muscle.Eur J Pharmacol 1981;75:109?113.","journal-title":"Eur J Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0002-8703(83)90116-3","volume":"106","author":"ED Freis","year":"1983","unstructured":"Freis ED. How diuretics lower blood pressure.Am Heart J 1983;106:185?187.","journal-title":"Am Heart J"},{"key":"CR22","first-page":"265","volume":"2","author":"AG Dupont","year":"1988","unstructured":"Dupont AG, Schoors DF, Six RO, et al. Antihypertensive efficacy of low dose torasemide in essential hypertension: A placebo-controlled study.J Human Hypertens 1988;2:265?268.","journal-title":"J Human Hypertens"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-199141010-00008","volume":"41","author":"HA Friedel","year":"1991","unstructured":"Friedel HA, Buckley MMT. Torasemide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension, congestive heart failure and oedema associated with renal and hepatic disease.Drugs 1991;41:81?103.","journal-title":"Drugs"},{"issue":"II","key":"CR24","first-page":"172","volume":"38","author":"AG Dupont","year":"1988","unstructured":"Dupont AG, Gerlo E, Van der Niepen P, et al. Renal hemodynamic effects of torasemide and furosemide in normal man.Arzneim Forsch\/Drug Res 1988;38(II):172?175.","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/clpt.1980.231","volume":"28","author":"JA Webster","year":"1980","unstructured":"Webster JA, Dollery CT. Antihypertensive action of bendroflumethiazide: Increased prostacyclin production.Clin Pharmacol Ther 1980;28:751?758.","journal-title":"Clin Pharmacol Ther"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.RES.42.3.376","volume":"421","author":"ED Vaughan Jr","year":"1978","unstructured":"Vaughan ED Jr, Carey RM, Peach MJ, et al. The renin response to diuretic therapy: A limitation of antihypertensive potential.Circ Res 1978;421:376?381.","journal-title":"Circ Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/clpt.1980.44","volume":"27","author":"P Brummelen Van","year":"1980","unstructured":"Van Brummelen P, Man in 't Veld AJ, Schalekamp MAHD. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and non-responders.Clin Pharmacol Ther 1980;27:328?336.","journal-title":"Clin Pharmacol Ther"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7326\/0003-4819-87-5-558","volume":"87","author":"MA Weber","year":"1977","unstructured":"Weber MA, Drayer JI, Rev A, et al. Disparate patterns of aldosterone response during diuretic treatment of hypertension.Ann Intern Med 1977;87:558?563.","journal-title":"Ann Intern Med"},{"key":"CR29","first-page":"307s","volume":"55","author":"G Leonetti","year":"1978","unstructured":"Leonetti G, Terzoli L, Sala C, et al. Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.Clin Sci Mol Med 1978;55:307s-309s.","journal-title":"Clin Sci Mol Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197410172911603","volume":"291","author":"H Gavras","year":"1974","unstructured":"Gavras H, Brunner HR, Laragh JH, et al. A converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertension.N Engl J Med 1974;291:817?821.","journal-title":"N Engl J Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9149(73)80044-X","volume":"32","author":"ED Vaughan","year":"1973","unstructured":"Vaughan ED, Laragh JH, Gavras I, et al. Volume factors in low and normal renin essential hypertension.Am J Cardiol 1973;32:523?532.","journal-title":"Am J Cardiol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(84)80062-5","volume":"77","author":"JH Laragh","year":"1984","unstructured":"Laragh JH. Modification of stepped care approach to antihypertensive therapy.Am J Med 1984;77:78?86.","journal-title":"Am J Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI104143","volume":"39","author":"ED Freis","year":"1960","unstructured":"Freis ED, Wanho A, Schnaper HE, et al. Mechanism of the altered blood pressure responsiveness induced by chlorothiazide.J Clin Invest 1960;39:1277?1281.","journal-title":"J Clin Invest"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ki.1983.22","volume":"23","author":"P Weidmann","year":"1983","unstructured":"Weidmann P, Beretta-Piccoli C, Meier A, et al. Antihypertensive mechanism of diuretic treatment with chlortalidone. Complementary roles of sympathetic axis and sodium.Kidney Int 1983;23:320?325.","journal-title":"Kidney Int"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cpt1979264428","volume":"26","author":"CR Lake","year":"1979","unstructured":"Lake CR, Ziegler MG, Coleman MD, et al. Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients.Clin Pharmacol Ther 1979;26:428?432.","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 2","key":"CR36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.RES.28.5_Suppl_2.II-76","volume":"28","author":"TG Coleman","year":"1971","unstructured":"Coleman TG, Granger HJ, Guyton AC. Whole-body circulatory autoregulation and hypertension.Circ Res 1971;28(Suppl 2):76?87.","journal-title":"Circ Res"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198309000-00004","volume":"62","author":"HE Wardener De","year":"1983","unstructured":"De Wardener HE, MacGregor GA. The relations of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension.Medicine 1983;62:310?326.","journal-title":"Medicine"},{"issue":"Suppl 2","key":"CR38","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00004872-199006002-00004","volume":"8","author":"RW Gifford Jr.","year":"1990","unstructured":"Gifford RW Jr. Long-term clinical trials in hypertension.J Hypertens 1990;8(Suppl 2):S17-S22.","journal-title":"J Hypertens"},{"issue":"Suppl 2","key":"CR39","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004872-199006002-00003","volume":"8","author":"M Moser","year":"1990","unstructured":"Moser M. Antihypertensive medications: Relative effectiveness and adverse reactions.J Hypertens 1990;8(Suppl 2):S9-S16.","journal-title":"J Hypertens"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","volume":"291","author":"Medical Research Council Working Party","year":"1985","unstructured":"Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results.Br Med J 1985;291:97?102.","journal-title":"Br Med J"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9149(85)90290-5","volume":"55","author":"Multiple Risk Factor Intervention Research Group","year":"1985","unstructured":"Multiple Risk Factor Intervention Research Group. Baseline resting electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial.Am J Cardiol 1985;55:1?15.","journal-title":"Am J Cardiol"},{"issue":"Suppl II","key":"CR42","first-page":"II45","volume":"11","author":"WB Kannel","year":"1988","unstructured":"Kannel WB, Cupplas LA, D'Agostino RB, et al. Hypertension, antihypertensive treatment, and sudden coronary death: the Framingham Study.Hypertension 1988;11(Suppl II):II45-II50.","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"CR43","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00004872-199006002-00005","volume":"8","author":"ED Freis","year":"1990","unstructured":"Freis ED. The cardiotoxicity of thiazide diuretics: Review of the evidence.J Hypertens 1990;8(Suppl 2):S23-S32.","journal-title":"J Hypertens"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.HYP.8.5.438","volume":"8","author":"RP Shannon","year":"1986","unstructured":"Shannon RP, Wei JY, Rosa RM, et al. The effect of age and sodium depletion on cardiovascular response to orthostasis.Hypertension 1986;8:438?443.","journal-title":"Hypertension"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/0003-4819-75-6-853","volume":"75","author":"MP Fichmann","year":"1971","unstructured":"Fichmann MP, Vorherr H, Kleeman CR, et al. Diuretic-induced hyponatremia.Ann Intern Med 1971;75:853?863.","journal-title":"Ann Intern Med"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-9343(81)90530-1","volume":"70","author":"OB Holland","year":"1981","unstructured":"Holland OB, Nixon JV, Kuhert L. Diuretic-induced ventricular ectopic activity.Am J Med 1981;70:762?768.","journal-title":"Am J Med"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0954-6820.1981.tb02640.x","volume":"Suppl 647","author":"JW Hollifield","year":"1981","unstructured":"Hollifield JW, Slaton PE. Thiazide diuretics, hypokalemia, and cardiac arrhythmia.Acta Med Scand 1981;Suppl 647:67?73.","journal-title":"Acta Med Scand"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/bmj.287.6401.1249","volume":"287","author":"Medical Research Council Working Party on Mild to Moderate Hypertension","year":"1983","unstructured":"Medical Research Council Working Party on Mild to Moderate Hypertension. Ventricular extra-systoles during thiazide treatment: Substudy of MRC mild hypertension trial.Br Med J 1983;287:1249?1253.","journal-title":"Br Med J"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/archinte.1984.04400020073013","volume":"144","author":"JE Madias","year":"1984","unstructured":"Madias JE, Madias NE, Gavras HP. Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension.Arch Intern Med 1984;144:2171?2176.","journal-title":"Arch Intern Med"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/archinte.1988.00380060036009","volume":"148","author":"V Papademetriou","year":"1988","unstructured":"Papademetriou V, Burris JF, Notargiacomo A, et al. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension.Arch Intern Med 1988;148:1272?1276.","journal-title":"Arch Intern Med"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(83)92140-2","volume":"1","author":"AD Struthers","year":"1983","unstructured":"Struthers AD, Whitesmith R, Reid JL. Prior thiazide diuretic treatment increases adrenaline-induced hypokalemia.Lancet 1983;1:1358?1360.","journal-title":"Lancet"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM198312083092303","volume":"309","author":"MJ Brown","year":"1983","unstructured":"Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta receptor stimulation of circulating epinephrine.N Engl J Med 1983;309:1414?1419.","journal-title":"N Engl J Med"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.71.4.645","volume":"71","author":"JE Norderhang","year":"1985","unstructured":"Norderhang JE, Johanessen KA, Von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction.Circulation 1985;71:645?649.","journal-title":"Circulation"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.1978.03290170045023","volume":"240","author":"MA Araoye","year":"1978","unstructured":"Araoye MA, Chang MY, Khatri IM, et al. Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension.JAMA 1978;240:1863?1866.","journal-title":"JAMA"},{"key":"CR55","first-page":"1015","volume":"145","author":"CVS Ram","year":"1981","unstructured":"Ram CVS, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension: Effects on potassium wastage and blood pressure control.Arch Intern Med 1981;145:1015?1019.","journal-title":"Arch Intern Med"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bmj.280.6218.905","volume":"230","author":"DB Morgan","year":"1980","unstructured":"Morgan DB, Davidson C. Hypokalemia and diuretics: An analysis of publications.Br Med J 1980;230:905?908.","journal-title":"Br Med J"},{"key":"CR57","unstructured":"Case DB, Pickering TG, Laragh JH. High sodium intake prevents adverse metabolic effects of diuretic treatment without reversing antihypertensive effect.Clin Res 1984;32:329A."},{"key":"CR58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-8703(79)90108-X","volume":"97","author":"T Dyckner","year":"1979","unstructured":"Dyckner T, Wester PO. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusion in patients on diuretic therapy.Am Heart J 1979;97:12?18.","journal-title":"Am Heart J"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1001\/jama.1983.03330440046030","volume":"249","author":"L Cohen","year":"1983","unstructured":"Cohen L, Kitzes R. Magnesium sulfate and digitalis-toxic arrhythmias.JAMA 1983;249:2808?2810.","journal-title":"JAMA"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/bmj.3.5827.620","volume":"2","author":"P Lim","year":"1972","unstructured":"Lim P, Jacobs E. Magnesium deficiency in patients on long-term diuretic therapy for heart failure.Br Med J 1972;2:620?622.","journal-title":"Br Med J"},{"issue":"Suppl","key":"CR61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1981.tb02651.x","volume":"647","author":"MP Ryan","year":"1981","unstructured":"Ryan MP, Ryan MF, Connihan TB. The effect of diuretics on lymphocyte magnesium and potassium.Acta Med Scand 1981;647(Suppl):153?161.","journal-title":"Acta Med Scand"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(82)91506-9","volume":"2","author":"MB Murphy","year":"1982","unstructured":"Murphy MB, Lewis PJ, Kohner E, et al. Glucose intolerance in hypertensive patients treated with diuretics; A 14-year follow-up.Lancet 1982;2:1293?1295.","journal-title":"Lancet"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/bmj.289.6457.1495","volume":"289","author":"C Bengtsson","year":"1984","unstructured":"Bengtsson C, Blohme G, Lapidus L, et al. Do antihypertensive drugs precipitate diabetes?Br Med J 1984;289:1425?1497.","journal-title":"Br Med J"},{"key":"CR64","first-page":"143","volume":"2","author":"AG Dupont","year":"1991","unstructured":"Dupont AG. Insulin sensitivity and hypertension.Eur J Med 1991;2:143?147.","journal-title":"Eur J Med"},{"key":"CR65","first-page":"123","volume":"1","author":"A Damhurst","year":"1985","unstructured":"Damhurst A, Powell SH, Pensky J. Aggravation by propranolol of hyperglycaemic effects of hydrochlorothiazide in type II diabetics without alteration of insulin secretion.Lancet 1985;1:123?126.","journal-title":"Lancet"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2337\/diab.32.2.106","volume":"32","author":"JH Helderman","year":"1983","unstructured":"Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium.Diabetes 1983;32:106?111.","journal-title":"Diabetes"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM198909283211305","volume":"321","author":"T Pollare","year":"1989","unstructured":"Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.N Engl J Med 1989;321:868?873.","journal-title":"N Engl J Med"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/0002-9343(76)90156-X","volume":"61","author":"RP Ames","year":"1976","unstructured":"Ames RP, Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension.Am J Med 1976;61:748?757.","journal-title":"Am J Med"},{"issue":"Suppl III","key":"CR69","doi-asserted-by":"crossref","first-page":"III120","DOI":"10.1161\/01.HYP.5.5_Pt_2.III120","volume":"5","author":"P Weidmann","year":"1983","unstructured":"Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins.Hypertension 1983;5(Suppl III):III120-III131.","journal-title":"Hypertension"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004872-198508000-00001","volume":"3","author":"P Weidmann","year":"1985","unstructured":"Weidmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteins.J Hypertens 1985;3:297?306.","journal-title":"J Hypertens"},{"issue":"Suppl 2A","key":"CR71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(86)90159-2","volume":"80","author":"SW MacMahon","year":"1986","unstructured":"MacMahon SW, Macdonald GJ. Antihypertensive treatment and plasma lipoprotein levels: The association in data from a population study.Am J Med 1986;80(Suppl 2A):40?47.","journal-title":"Am J Med"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7326\/0003-4819-97-2-206","volume":"97","author":"K Boehringer","year":"1982","unstructured":"Boehringer K, Weidmann P, Madosini R, et al. Menopausedependent plasma lipoprotein alterations in diuretic treated women.Ann Intern Med 1982;97:206?209.","journal-title":"Ann Intern Med"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.1988.00380060044012","volume":"148","author":"CK Lardinois","year":"1984","unstructured":"Lardinois CK, Neumann SI. The effect of antihypertensive agents on serum lipids and lipoproteins.Arch Intern Med 1984;148:1280?1288.","journal-title":"Arch Intern Med"},{"key":"CR74","first-page":"539","volume":"8","author":"Medical Research Council Working Party on Mild to Moderate Hypertension","year":"1981","unstructured":"Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to dendrofluazide and propranolol for the treatment of mild hypertension.Lancet 1981;8:539?542.","journal-title":"Lancet"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(81)92624-6","volume":"1","author":"G Berglund","year":"1981","unstructured":"Berglund G, Andersson O. Beta-blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side effects.Lancet 1981;1:744?747.","journal-title":"Lancet"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","volume":"90","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease.Ann Intern Med 1979;90:85?91.","journal-title":"Ann Intern Med"},{"key":"CR77","first-page":"1947","volume":"144","author":"Lipids Research Clinics Primary Prevention Trial Results","year":"1984","unstructured":"Lipids Research Clinics Primary Prevention Trial Results. II. Relationship of reduction in incidence of coronary heart disease to cholesterol lowering.JAMA 1984;144:1947?1953.","journal-title":"JAMA"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-199001000-00002","volume":"8","author":"HR Brunner","year":"1990","unstructured":"Brunner HR, M\u00e9nard J, Waeber B, et al. Treating the individual hypertensive patients: Considerations on dose, sequential monotherapy and drug combination.J Hypertens 1990;8:3?11.","journal-title":"J Hypertens"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archinte.1990.00390180019003","volume":"150","author":"RR Townsend","year":"1990","unstructured":"Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension.Arch Intern Med 1990;150:1175?1183.","journal-title":"Arch Intern Med"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","unstructured":"80.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.JAMA 1991;265:3255?3264.","journal-title":"JAMA"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","volume":"338","author":"N Dahl\u00f6f","year":"1991","unstructured":"Dahl\u00f6f N, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).Lancet 1991;338:1281?1285.","journal-title":"Lancet"},{"key":"CR82","first-page":"505","volume":"304","author":"MRC Working Party","year":"1992","unstructured":"MRC Working Party, Medical Research Council trial of treatment of hypertension in older adults: principal results.Brit Med J 1992;304:505?512.","journal-title":"Brit Med J"},{"key":"CR83","first-page":"580","volume":"6","author":"JIS Robertson","year":"1992","unstructured":"Robertson JIS. The case for antihypertensive drug treatment in subjects over the age of sixty.Cardiovasc Drugs Ther 1992;6:580?583.","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00877958\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T05:39:22Z","timestamp":1706074762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00877958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":83,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF00877958"],"URL":"https:\/\/doi.org\/10.1007\/bf00877958","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}